Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag in pediatric chronic immune thrombocytopenia
NCT04102033Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Nov 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by Assiut University. Status: unknown.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT04102033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04102033.